Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Healthequity (HQY) Share Price
Media coverage about Healthequity (NASDAQ:HQY) has trended somewhat positive on Friday, Accern Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Healthequity earned a daily sentiment score of 0.21 on Accern’s scale. Accern also gave news stories about the company an impact score of 47.2724328371525 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the news stories that may have effected Accern’s scoring:
- Should You Buy HealthEquity (HQY) Ahead of Earnings? – Nasdaq (nasdaq.com)
- Insider Selling: Healthequity Inc (HQY) Director Sells 49,900 Shares of Stock (americanbankingnews.com)
- HealthEquity Is Undervalued With Double-Digit Growth Ahead – Seeking Alpha (seekingalpha.com)
- Healthequity Inc (HQY) VP Sells $624,000.00 in Stock (americanbankingnews.com)
A number of analysts have recently issued reports on HQY shares. Zacks Investment Research upgraded Healthequity from a “hold” rating to a “buy” rating and set a $58.00 target price for the company in a report on Wednesday, October 11th. Citigroup initiated coverage on Healthequity in a research report on Thursday, January 4th. They set a “buy” rating on the stock. Chardan Capital boosted their price target on Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a research report on Wednesday, December 6th. Cantor Fitzgerald reissued a “buy” rating and set a $56.00 price target on shares of Healthequity in a research report on Tuesday, December 5th. Finally, BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research report on Tuesday, November 7th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $58.00.
Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. The firm had revenue of $56.80 million for the quarter, compared to analyst estimates of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. Healthequity’s revenue for the quarter was up 31.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.10 EPS. research analysts forecast that Healthequity will post 0.71 EPS for the current year.
In other Healthequity news, EVP Delano Ladd sold 26,405 shares of the company’s stock in a transaction that occurred on Tuesday, December 12th. The stock was sold at an average price of $43.32, for a total value of $1,143,864.60. Following the transaction, the executive vice president now directly owns 16,692 shares of the company’s stock, valued at approximately $723,097.44. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Ashley Dreier sold 12,000 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $52.00, for a total value of $624,000.00. Following the completion of the transaction, the vice president now directly owns 17,652 shares in the company, valued at $917,904. The disclosure for this sale can be found here. Insiders have sold a total of 1,164,430 shares of company stock worth $60,844,765 over the last three months. 29.00% of the stock is currently owned by corporate insiders.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.